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Anti-neutrophil cytoplasmic antibodies (ANCA) were lirst described in Wegener's
granulomatosis (WG), a disease which is characterized by granulomatous inflammation in the
upper and lorver respiratory tract, systemic vasculitis affècting small blood vessels, and pauci-
immune necrotizing crescentic glomemlonephritis. The close association between active WG
and ANCA directed against proteinase 3 (PR3) suggested an autoimmune pathogenesis of
WG. To date, the etiology and pathogenesis of ANCA-associated vasculit ides, including WG,
is not completely understood. It is firmly established that PR3-ANCA is a specific rnarker for
WG and that the detection of these autoantibodies i helpful in the diagnosis and follow-up of
WG patients. In addition, an increase in levels of PR3-ANCA precedes a relapse of WG in many
cases, suggesting that ANCA may play a direct role in the pathogenesis of ANCA-associated
vasculitides. Several in v'itro observations further underline the hypothesis that ANCA are
involved in the pathogenesis of WG. PR3-ANCA have been shown to activate primed
neutrophils to the production of reactive oxygen species and to degranulation of lysosornal
cnzymes, including PR3. Furlhermore, PR-I-ANCA can interfere with the proteolyic activity
o1'PR3 and with the complexation of PR3 to its physiological inhibitor a1-antitrypsin (ul-AT).
Most imporlantly, the latter two functional characteristics of PR3-ANCA correlate rvith disease
activity of WG. It has been described that changes in these functional characteristics of ANCA
follow changes in disease activity rnore accurately than the previously mentioned changes in
ANCA titers alone. This suggests that epitope specificity of PR3-ANCA is related to these
functional characteristics of PR3-ANCA and to disease activity in WG.
Based on the above mentioned observations three questions were raised that we set out to
address in this thesis. First, what are the epitopes on the PR3 molecule that are recognized by
PR3-ANCA positive sera of patients with WG? Secondly, is there a spreading of epitopes
recognized by PR3-ANCA positive sera in relation to changes in the disease activity of WG?
And thirdly, is there a relation betu,een the epitope specilicity of PR3-ANCA positive sera
and the functional activitv of PR3-ANCA?
ln Chapter 2 we summarized the literature on the possible pathophysiological role of ANCA
in ANCA-associated vasculitides. In vitro experimental work has extensively analyzed the
efÍècts of ANCA on neutrophils and rnonocy,tes. From those in ,-iíro obsewations, we
extracted four prerequisites for ANCA mediated endothelial cell damage; the presence of
ANCA, expression of the target antigcns for ANCA on primed neutrophils and monocytes,
the necessity of an interaction between prirned neutrophils and endothelium via B2-integrins,
and finally, activation of endothelial cells. In this chapter we connected these prerequisites
extracted frorr in lllro obseryed effects of ANCA Ío in vivo obseruations in patients with
ANCA-associated vasculitides. We tried to explain whether in vilro effects may result into
systemic inflammation, damage of blood vessels, and pauci-immune glomerulonephritis as
seen in Datients with ANCA-associated vasculit ides.
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SUMMARY
Little is known about the epitopes on PR3 that are recognized by PR3-ANCA as elucidation
of these epitopes has been hampered by the fact that the majority of PR3-ANCA recognizes
conformational epitopes. Antibody binding to PR3 is abrogated by exposure of PR3 to
reducing or denaturing agents. In order to elucidate the epitopes on PR3 recognized by PR3-
ANCA, the 3D structure of PR3 has to be preserved. Chapter 3 describes the characterization
of monoclonal antibodies (mAbs) to PR3. These mAbs can be used as tools for epitope
mapping studies of PR3-ANCA positive sera. Thirleen anti-PR3 mAbs, including nine widely
used in diagnostic tests and four newly raised mAbs were tested. The antigen specificity was
assessed by indirect immunofluorescence, immunoblotting, FACS analysis and antigen
specific ELISA. The competition between the anti-PR3 mAbs in binding to PR3 was
investigated by biosensor technology using the BIAcore. Interestingly, the anti-PR3 mAbs
recognized a restricted number of four epitope areas on PR3 only. Two of the four newly
raised mAbs recognized an epitope area on PR3 different from the established mAbs, thus
enabling the detection of a broader range of epitope specificities of anti-PR3 antibodies. In
preliminary studies some of the established mAbs were used in inhibition studies with PR3-
ANCA positive sera. These mAbs were shown to bind to comparable pitopes areas as PR3-
ANCA positive sera. Thus, these mAbs can serve as tools for epitope mapping. The restricted
number of epitope areas recognizedby mAbs on PR3, being a small and extensively folded
protein, may suggest hat the human anti-PR3 response in WG is also restricted.
As already mentioned PR3-ANCA mainly recognizes conformational epitopes on PR3.
Conformational epitopes can best be identified by X-ray crystallography, nevertheless ome
epitopes defined by this method can also be identified by overlapping linear peptides. In
chapter 4 we used overlapping linear peptides ofthe entire sequence ofPR3 to further define,
possibly relevant, linear epitopes on PR3 recognized by PR3-ANCA of patients with WG.
Sera of patients with WG as well as sera of healthy controls recognized five distinct peptide
areas. Four of these peptide areas were significantly better bound by sera from patients with
WG than by sera from healthy controls. Most interestingly, only sera of patients during their
initial presentation of WG were responsible for the increased binding to these four distinct
peptide areas. Two of these peptide areas were located near the active center of PR3, at the
active site amino acids Hisaa and Serl76. The other two peptide areas were located at the N-
terminus and in the center of the PR3 sequence. All peptides recognized were surface
accessible and coincided to some extent with earlier described epitopes that are recognized by
PR3-ANCA. The amino acid sequences of the recognized peptide areas were highly specific
for serine proteases but not specific for PR3 alone. Rabbit anti-PR3 antiserum recognized
three distinct peptide areas, partly overlapping the areas recognized by PR3-ANCA positive
sera, whereas none of the anti-PR3 mAbs recognized linear PR3 peptides.
Sera of healthy controls recognized peptides of PR3 but did not bind to the whole PR3
protein, whereas sera of WG patients did. These data suggest hat the autoimmune response to




and evolves into responses to conformational epitopes. Furthetmore, it is suggested that upon
relapse of WG epitope spreading of PR3-ANCA to more confonnation dependent epitopes
occurs resulting in PR3-ANCA that binds linear peptides with lower affinity.
ln the previous chapter it was suggested that upon relapse of WG epitope spreading of PR3-
ANCA occurs. In chapter 5 we investigated whether these changes in epitope specificity of
pR3-ANCA that occur during the course of tlre disease result in changes in functionality of
pR3-ANCA. Sera of WG patients during active phase of disease or during retnission were
compared for their capacity to interfere with the proteolyic activity of PR3. The proteolytic
activity of PR3 was determined u,ith two different substrates; i.e. a small synthetic peptide
substrate and a larger more physiological substrate, namely casein. Most of the PR3-ANCA
sanples inhibited the proteoly.tic activity of PR3. Especially with casein as a substrate, it was
shown that, using a fixed amount of IgG, total IgG from patients with active disease had a
higher inhibitory capacity towards the proteolytic activity of PR3 than IgG Í}om patients
during remission of WG. Furthermore, only for samples taken during active disease a
correlation was observed between PR3-ANCA titer and their capacity to interfere with the
proteoll'tic activity of PR3. For both substrates PR3-ANCA of patients during remission had a
relatively higher inhibitory capacity towards the proteolyic activity of PR3 than PR3-ANCA
of patients during an active phase. This may indicate that during disease exacerbation a shill
in epitope specificity of PR3-ANCA occurs, rvhich may have relevance for the pathogenicity
of the antibodies in ANCA-associated vasculitides.
T cell-rnediated immunity is thought to play an important role in the pathogenesis of
granulomatous inflammation and vasculitis as found in patients with WG. The relevant
epitopes responsible tbr this T cell-mediated in-rmunity have not been identihed yet. Chapter
6 describes Íhe in vitro proliferative responses to PR3 and linear peptides of PR3 by
peripheral blood mononuclear cells (PBMCs) of patients with WG. The same set of peptides
as used in the study described in chapter 4 was used. PBMCs of two WG patients and one
healthy control proliferated to the whole PR3 molecule as well as to peptide pools. In
addition, PBMCs from ten WG patients and from eight healthy controls who did not
proliferate to the whole PR3 molecule did proliferate to pools of PR3 peptides. Although
more WG patients tended to react to particular peptide pools, no signilicant difference was
seen between WG patients and healthy controls. Thus, T cells of WG patients proliferate in
vitr.o more frequently to PR3 peptides than to the whole PR3 protein. lnterestingly, the highest
levels of proliÍ'eration of WG patients and healthy controis were seen to peptides derived from
the signal-sequence, the propeptide and the C-terminus ofthe PR3 sequence. These sequences
of PR3 difÍèr in various amino acids from HLE. The identihed T cell epitopes nright be
specihc for the PR3 sequence.
These data suggest hat autoreactive T cells specific for peptides of PR3 are present in both
WG patients and healthy controls. The proliferative response to whole PR3 was low in
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patients with PR3-ANCA. A sirnilar lack of response was seen in animals ir.nrnunized with
PR3. Possibly, the antigen that induces the T cell help for anti-PR3-specific B cells in WG
patients is not PR3 itself but a protein complexed to PR3.
PR3 has been identified as the major autoantigen for ANCA in WG. For diagnostic purposes
and to Íurther study the pathophysiological role of PR3-ANCA in WG and to delineate the
specific epitopes reactive with PR3-ANCA, highly purified PR3 is an important prerequisite.
The usual method for its purification requires large amounts of blood and is laborious with
relatively tow yields. In addition. the presence of trace amounts of other autoantigens that
maybe co-purified can never be ruled out completely. Therefore, we produced a recombinant
form of PR3 and investigated whether this fonn of recombinant PR3 (rPR3) could be used for
detection of PR3-ANCA in WG patients. Earlier studies atternpting to produce rPR3 showed
that expression of PR3 in bacteria is often accompanied by a loss of binding by PR3-ANCA
positive sera. Therefore, we produced PR3 in the eukaryotic expression system of the
methylothrophic yeast Pichia pastons as well as in the bacteria E. coli as described in
Chapter 7. Pichio pasíoris, when grown on methanol as the sole carbon source, produces
massive amounts of Íhe AOXI (alcohol oxidase l) gene product. The open reading frame of
human PR3 without the pre-pro-peptide was cloned and expressed in E. coli (rcPR3) and in
Pichict Ttuston,s (ryPR3) behind the strong AOXI prontoter. On SDS-PAGE the rcPR3 had the
full length size of neutrophil PR3 and reacted with a polyclonal rabbit anti-PR3 serum.
Unfortunately, only a minority of PR3-ANCA positive sera recognized this rcPR3. RpPR3
expressed with a 6-histidine tag was efÍ'iciently secreted into the culture supernatant. The
secreted rpPR3 could be isolated through immobilized metal chelate chromatography. For
three separate purifications this yielded 613 + 122 1t"g rpPR3 per liter induced culture
supernatant. Purified rpPR3 rnigrated as a single 32 kDa band on SDS-PAGE. RpPR3 proved
to be proteollically active and specifrc serine protease inhibitors like cxl-antitrypsin and
PMSF could inhibit its proteoly'tic activity. Seven out of ten sera frorn patients with WG
recognized rpPR3 in an antigen specific capture ELISA. This suggests that the folding of
rpPR3 approaches that of neutrophil PR3. Neverlheless, direct binding to the ELISA plates of
any of the types of rPR3 lowered the binding of at least some WG sera. Since not all sera of
WG patients recognized rpPR3 it cannot replace neutrophil human PR3 for diagnostic
pulposes at this stage.
As production of rPR3 rvhich may replace neutrophil PR3 for diagnostic purposes proved
more difficult than first expected we compared rPR3 produced in different expression systelns
on their recognition by anti-PR3 antibodies. Chapter 8 describes the comparison between
rPR3 produced in Ë. coll (rcPR3), P. pasÍoris (rpPR3), insect cells using the baculovirus
system (rbPR3), the human mast cell l ine, HMC-l (HMC-1/PR3-Sl76A). or the human
epithelial cell line 293 (A-rPR3-S176A) as well as purified neutrophil PR3 on their
recognition by anti-PR3 antibodies. All forrns of rPR3 were recognized by rabbit serum raised
1 8 7
CHAPTER I I
against PR3 on immunoblot, in caphrre ELISA and in direct ELISA system. By capture
ELISA rcPR3 and rpPR3 were recognized by 1\ (57%) and 13 (68%)of the 19 PR3-ANCA
sera, respectively, whereas rbPR3, HMC-1/PR3-Sl76A, A-rPR3-Sl76A and neutrophil PR3
$'ere recognized by all PR3-ANCA sera. Using the dilect ELISA none of the PR3-ANCA
sera recognized rcPR3, whereas rpPR3 and rbPR3 were recognized by 2 (l l%) and l7 (89%)
of the l9 PR3-ANCA sera, respectively. All thirleen anti-PR3 nrAbs recognized neutrophil
PR3 in the direct as well as in the capture ELISA. The rcPR3 was recognized by 2 mAbs in
the capture ELISA but by none of the mAbs in the direct ELISA. The rpPR3 was recognized
by 7 mAbs in the capture ELISA and only by 2 mAbs in the direct ELISA. All but one of the
anti-PR3 mAbs recognized rbPR3, whereas HMC-1/PR3-Sl76A and Á-rPR3-Sl76A were
recognized by all anti-PR3 mAbs. Thus, our results demonstrate that rPR3 produced in a
prokaryotic expression system is recognized only by a minority of anti-PR3 antibodies
whereas PR3 produced in higher eukaryotic expression systems is recognized by rnost. if not
all, tested antibodies to neutrophil PR-3.
Reviewing the literature on rPR3 together with the data of this study several prerequisites
were formulated for the production of rPR3 that is well bound by PR3-ANCA sera. Essential
for the production ofantigenic rPR3 is its secretion or localization in granules either by using
a secretion signal or by using the leader sequence of PR3 itself. Cleavage of the N-terminal
PR3 propeptide appears cmcial for the expression of the complete array of epitopes
recognized by PR3-ANCA. Finally, rnammalian like glycosylation may contribute to the
proper fblding of PR3. In contrast, the C-terminal processing of PR3 does not appearto affect
antigenicity.
Keeping the above mentioned prerequisites in mind we produced PR3 in a higher eukaryotic
explession system. Chapter 9 describes the expression of recombinant PR3 in insect cells
using the baculovirus expression system. Two forms of rPR3 containing the propeptide of
PR3 with or without a C-terminal His-tag (rproPR3-his and rproPR3, r'espectively) and two
fomrs of rPR3 without the propeptide and with or without a C-terminal His-tag (rPR3-his and
rPR3, respectively) were expressed in insect cells. By virtue of the honeybee mellitin signal
sequence the four forms of recornbinant PR3 were efficiently secreted into the culture
medium of the infected insect cells. On SDS-PAGE these four recombinant PR3s migrated at
approxirnately 32 kDa and were larger compared to neutrophil PR3. AÍier fbur days of
infection the production level of the rPR.is rvas approximately 2 trrg/ml, which is cor.nparable
to another study on rPR3 expressed in insect cells. All four rPR3 variants were recognized by
a rabbit serum raised against PR3 and by at least two anti-PR3 mAbs. All four rPR3 variants
were recognized by seventeen of eiglrteen PR3-ANCA sera tested in a capture ELISA system.
So, the presence of a C-terminal His-tag did not interfere with the antigenicity. The rPR3
containing a C-terminal His-tag, rPR3-his and rproPR3-his, could be isolated through
immobilized metal chelate chromatography. Most interestingly both the mature and the
proform of PR3 were enzymatically active. As almost a1l tested sera of WG patients
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recognized these four rPR3 variants thcse variants of PR3 possibly can replace neutrophil
PR3 for diagnostic purposes. Furthermore, these rPR3s, or substitution mutants of these
rPR3s, can serve as important tools Íbr studying epitope mapping and for studies on the
pathophysiological role of PR3-ANCA in WG. In order to assess the use of recornbinant PR3
expressed in insect cells in diagnostic tests, the recognition of this rPR3 by a large set of
clinically relevant patient sera has to be determined.
PR3 is one of lbur serine protease homologues in the azurophilic granules of ner.rtrophils and
granules of monocytes. ANCA in patients with WG are mainly directed against PR3 and PR3.
and not its horlologues, is overexpressed in a variety of acute and chronic myeloid leukemia
cells. Furthermore, cltotoxic T lymphocyes specific for a PR3 derived peptide have been shown
to specifically lyse leukemia cells that overexpress PR3. hr chapter l0 we summarize the
literature on PR3 and the characteristics of PR3 which may implicate PR3 in the pathogenesis
of WC and as target for imnruno-therapy in nryeloid leukernia. We focused on the genetic
localization and gene regulation of PR3, the processing, storage, and expression of the PR3
protein, and the physiological functions of PR3. Three main differences between PR3 and the
other neutrophil derived serine proteases. that is human leukocy.te lastase (HLE), cathepsin G
(CatG) and azurocidin (AZU) were observed. PR3 is, apart frorr.r its presence in azuropl.rilic
granules. also present in the secretory vesicles and in specific granules of PMNs, and PR3 is
expressed on the plasma membrane of resting neutrophils. Most impoÍantly, this mernbrane
expression is bimodal and the presence of a high percentage of neutrophils with PR3
membrane expression is a risk Íactor fbr vasculitis. Secondly, the role described Íbr PR3 as a
feedback regulator in myeloid differentiation has not been suggested for the other PMN
derived serine proteases. Thirdly, PR3, both enzymatically active and inactive, binds to and
enters human endothelial cells. Upon binding PR3 can activate these cells and induce
apoptosis of endothelial cells. This apoptosis induction rvas ascribed to an enzymatically
inactive C-terrninal domain of PR3. The significance of the above mentioned differences
between PR3 and the other neutrophil derived serine proteases in our understanding of the
role of PR3 in the pathogenesis of WG or as target for immuno-therapy in myeloid leukemia
has still to be detennined. In conclusion, PR3 is a very intriguing protein with a large array of





In this thesis we tried to address three questions. First, we wanted to elucidate the epitopes on
the PR3 molecule that are recognized by PR3-ANCA positive sera of patients with WG. As
already mentioned tbr the determination of the epitopes recognized by PR3-ANCA positive
sera of WG patients it is important that the 3D structure of PR3 is preserued, which rrrakes
epitope mapping a difficult task.
Using linear peptides of the entire PR3 sequence four epitope areas were identified. Two of
these epitope areas were located near the active center of PR3. The other two peptide areas
were located at the N-tenninus of the mature Íbrm of PR3 and in the center of the PR3
sequence. No epitopes were detected at the C-terminus of PR3 nor in the signalsequence or in
the prosequence. lJnfortunately, the amino acid sequence ofthe recognized peptide areas was
not specific for PR3 alone. Also, in the study described in chapter 5 most of the PR3-ANCA
IgG samples interÍèred with the proteoll.tic activity of PR3 btÍ not with the proteoly'tic
activity of HLE. This suggests that most PR3-ANCA positive sera recognize epitopes located
at or near the active site of PR3. However, the active site of PR3 has large homology with
murine PR3 and, to a lesser extent, with HLE. Still, PR3-ANCA do not react with murine PR3
or HLE. Along with the homology in primary sequence a difference in conforrrration of the
protein could influence the recognition by antibodies. Since PR3-ANCA mainly recognize
conformational epitopes this conlbrmational ditlerence might be of crucial importance for the
antigen-specificity.
This importance of the 3D structure and of proper processing of PR3 for the expression of the
complete array of epitopes recognized by PR3-ANCA hampered the procluction of an
antigenic reconrbinant PR3. Not withstanding these problems rve succeeded in the production
of a recombinant PR3 which possibly can replace neutrophil PR3 for diagnostic purposes. By
amino acid substitutions or deletion of small parts of this recombinant PR3, and still keeping
its 3D structure intact, the epitopes recognized by PR3-ANCA could possibly be further
delineated and narrowed down to specific areas on the PR3 nrolecule.
Thus, PR3-ANCA do not bind to one immuno-dominant epitope on PR3 but, possibly, in
alliance with mAbs to PR3, recognize only a restricted number of epitope areas.
In Wegener's granulomatosis B cel1s producing PR3-ANCA need help from autoreactive T
cells. The peptides responsible for the highest level of proliferative response of T cells were
located in the signal-sequence, the propeptide and the C-terminus of PR3. Epitopes
recognized by PR3-ANCA sera of WG patients do not correspond to epitopes recognized by
T cells of WG patients and healthy controls. The signal-sequence, the propeptide and the C-
terminus are removed upon processing of PR3, which may explain the low proliferative
response to the PR3 molecule. However, autoreactive T cells to linear peptides of the PR3
sequence are present in both WG patients and healthy controls. A lack of response to whole
PR3 was seen in most patients as well as in animals immunized with PR3. Possibly, the
antigen inducing T cell help for anti-PR3-specific B cells in WG patients is not PR3 itself but
a protein complexed to PR3. For further research on the epitopes recognized by T cells in WG
--
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crude extracts of neutrophils or PR3 conrplexed to other substances uch as anti-proteases
may be of use.
The second question we wanted to address was concerned with spreading of epitopes
recognized by PR3-ANCA positive sera in relation to changes in disease activity of WG. We
have shown that only sera of patients during their initial presentation of WG recognized linear
peptides significantly better than sera frorn healthy controls. This suggests that upon relapse
of WG spreading of epitopes that are recognized by PR3-ANCA to more conformation
dependent epitopes has occurred resulting in PR3-ANCA that bind linear peptides with lower
affinity.
The third question concerning the relation between the epitope specificity of PR3-ANCA
positive sera and the functional activity of PR3-ANCA. We have shown that, using a fixed
amount of IgG, total IgG frorn patients with active disease had a higher inhibitory capacity
towards the proteolltic activity of PR3 than IgG Íiorn patients during rernission of WG.
Furthermore, PR3-ANCA of patients during remission had a relatively higher inhibitory
capacity towards the proteolltic activity of PR3 than PR3-ANCA of patients during an active
phase. These data indicate that, during disease xacerbation, a change in epitope specificity of
PR3-ANCA may lead to a change in functional activity. IJowever, whether these changes in
lirnctional activity lead to a change in the pathogenicity of ANCA, such as their capacity to
activate neutrophils to degranulate and produce oxygen radicals or the capacity to interfere
with the inhibition of PR3 by crl-AT, still has to be determined. Experiments investigating
this are currently performed.
In conclusion, this study has contributed to our understanding of PR3 as an autoantigen in
WG. Tools have been generated to lirrther explore the interaction between PR3 and PR3-
ANCA. Recombinant PR3 and anti-PR3 mAbs can be used for diagnostic purposes.
Recombinant PR3 can furthermore be used for studies airned at a fuilher characterization of
the epitopes on PR3 that are recognized by PR3-ANCA. This, hopefully, will lead to
elucidation of the pathogenesis of the associated isease, Wegener's granulomatosis.
--
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